UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
Commission File No.
(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
| (Zip Code) |
( |
(Issuer’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
Soligenix, Inc., a Delaware corporation (the “Company”), believes that as of the date of this Current Report on Form 8-K it is in compliance with The NASDAQ Stock Market’s requirement that the Company have shareholders’ equity of at least $2,500,000 as a result of (i) the conversion of $154,840 of debt into equity on April 15, 2024 and (ii) the Company’s $4.75 million public offering, which closed on April 22, 2024. The equity financing and the debt conversion have been previously reported, including under Note 8. (Subsequent Events) to the Company’s condensed consolidated financial statements for the quarter ended March 31, 2024 which were filed as part of the Company’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 10, 2024.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
| Description |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Soligenix, Inc. | |
May 17, 2024 | By: | /s/ Christopher J. Schaber |
|
| Christopher J. Schaber, Ph.D. |
President and Chief Executive Officer | ||
(Principal Executive Officer) | ||
3
Document and Entity Information |
May 17, 2024 |
|---|---|
| Document and Entity Information [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | May 17, 2024 |
| Entity File Number | 001-14778 |
| Entity Registrant Name | Soligenix, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 41-1505029 |
| Entity Address, Address Line One | 29 Emmons Drive |
| Entity Address, Adress Line Two | Suite B-10 |
| Entity Address, City or Town | Princeton |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 08540 |
| City Area Code | 609 |
| Local Phone Number | 538-8200 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $.001 per share |
| Trading Symbol | SNGX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0000812796 |
| Amendment Flag | false |